IGF1 and diabetes mellitus: PI3K/AKT is a well‐documented pathway associated with human cancer risk that heavily regulates glucose and IGF signaling39; therefore, it is possible that the expression of PTPN2 interacts with diabetes through regulation of a variety of tyrosine kinases, given that tyrosine kinase activity of the insulin receptor is associated with human diabetes.40